BioNexus Gene Lab Corp. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
BioNexus Gene Lab Corp. (BGLC) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$174.31 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-08-14
- 2026-06-30: Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 month -$174.31K.
- 2025-06-30: Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 month -$260.30K.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 month |
|---|---|
| 2026-06-30 | -$174.31K 10-Q · filed 2026-08-14 |
| 2025-06-30 | -$260.30K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |